Lourdes Hermosín

418 total citations
11 papers, 222 citations indexed

About

Lourdes Hermosín is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Lourdes Hermosín has authored 11 papers receiving a total of 222 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 5 papers in Genetics and 3 papers in Molecular Biology. Recurrent topics in Lourdes Hermosín's work include Acute Myeloid Leukemia Research (7 papers), Chronic Myeloid Leukemia Treatments (3 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers). Lourdes Hermosín is often cited by papers focused on Acute Myeloid Leukemia Research (7 papers), Chronic Myeloid Leukemia Treatments (3 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers). Lourdes Hermosín collaborates with scholars based in Spain, United Kingdom and Italy. Lourdes Hermosín's co-authors include María Díez‐Campelo, Dolors Colomer, Antonio Jiménez, Juan A. Castillejo, Anabel Heiniger, Francisco Cervantes, José Román‐Gómez, Ángel León, A Grañena and Concepción Boqué and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Lourdes Hermosín

11 papers receiving 216 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lourdes Hermosín Spain 7 142 91 81 31 19 11 222
Chandrakala Shanmukhaiah India 11 228 1.6× 140 1.5× 93 1.1× 25 0.8× 9 0.5× 53 319
Carme Talarn Spain 8 206 1.5× 129 1.4× 104 1.3× 42 1.4× 10 0.5× 13 293
Bernardine Favre France 8 129 0.9× 73 0.8× 72 0.9× 31 1.0× 22 1.2× 14 187
S. A. Wang United States 6 191 1.3× 68 0.7× 69 0.9× 9 0.3× 17 0.9× 7 267
Paweł Kuś Poland 4 160 1.1× 80 0.9× 58 0.7× 19 0.6× 10 0.5× 6 233
Alexander Sternberg United Kingdom 7 203 1.4× 107 1.2× 68 0.8× 22 0.7× 17 0.9× 14 278
Zonghong Shao China 8 117 0.8× 60 0.7× 68 0.8× 20 0.6× 18 0.9× 29 180
Tiago Maié Germany 7 69 0.5× 61 0.7× 99 1.2× 25 0.8× 10 0.5× 17 181
H. Kreipe Germany 5 124 0.9× 48 0.5× 42 0.5× 9 0.3× 22 1.2× 13 172
Friederike Pastore Germany 8 255 1.8× 131 1.4× 164 2.0× 20 0.6× 7 0.4× 12 303

Countries citing papers authored by Lourdes Hermosín

Since Specialization
Citations

This map shows the geographic impact of Lourdes Hermosín's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lourdes Hermosín with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lourdes Hermosín more than expected).

Fields of papers citing papers by Lourdes Hermosín

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lourdes Hermosín. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lourdes Hermosín. The network helps show where Lourdes Hermosín may publish in the future.

Co-authorship network of co-authors of Lourdes Hermosín

This figure shows the co-authorship network connecting the top 25 collaborators of Lourdes Hermosín. A scholar is included among the top collaborators of Lourdes Hermosín based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lourdes Hermosín. Lourdes Hermosín is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Bilbao, Cristina, Ruth Stuckey, Estrella Carrillo‐Cruz, et al.. (2022). Next-Generation DNA Sequencing-Based Gene Panel for Diagnosis and Genetic Risk Stratification in Onco-Hematology. Cancers. 14(8). 1986–1986. 6 indexed citations
2.
Sánchez‐García, Joaquín, José Falantes, Lourdes Hermosín, et al.. (2017). Prospective randomized trial of 5 days azacitidine versus supportive care in patients with lower-risk myelodysplastic syndromes without 5q deletion and transfusion-dependent anemia. Leukemia & lymphoma. 59(5). 1095–1104. 14 indexed citations
3.
Abáigar, María, Cristina Robledo, Rocí­o Benito, et al.. (2016). Chromothripsis Is a Recurrent Genomic Abnormality in High-Risk Myelodysplastic Syndromes. PLoS ONE. 11(10). e0164370–e0164370. 27 indexed citations
4.
Sánchez-García, Jorge, José Falantes, Ana Medina, et al.. (2015). 114 FINAL RESULTS OF PHASE II RANDOMIZED TRIAL OF AZACITIDINE VERSUS SUPPORT TREATMENT IN PATIENTS WITH LOW RISK MYELODYSPLASTIC SYNDROME WITHOUT THE 5Q DELETION. Leukemia Research. 39. S59–S59. 3 indexed citations
5.
Remacha, Ángel F., Beatriz Arrizabalaga, Ana Villegas, et al.. (2014). Evolution of iron overload in patients with low-risk myelodysplastic syndrome: iron chelation therapy and organ complications. Annals of Hematology. 94(5). 779–787. 48 indexed citations
6.
Abáigar, María, Fernando Ramos, Rocí­o Benito, et al.. (2013). Prognostic impact of the number of methylated genes in myelodysplastic syndromes and acute myeloid leukemias treated with azacytidine. Annals of Hematology. 92(11). 1543–1552. 14 indexed citations
7.
Garcı́a, Juan Luis, María Jesús Peñarrubia, José Antonio Queizán, et al.. (2012). Incidence and clinical characteristics of myeloproliferative neoplasms displaying a PDGFRB rearrangement. European Journal Of Haematology. 89(1). 37–41. 27 indexed citations
8.
Remacha, Ángel F., Beatriz Arrizabalaga, Ana Villegas, et al.. (2012). The IRON2 Study. A Retrospective Observational Study to Describe the Evolution of Iron Overload in Patients with Low-Risk Myelodysplastic Syndrome. Blood. 120(21). 1723–1723. 4 indexed citations
9.
Abáigar, María, Fernando Ramos, Rocí­o Benito, et al.. (2012). Prognostic Impact of the Number of Methylated Genes in Myelodysplastic Syndromes and Acute Myeloid Leukemias Treated with 5-Azacytidine. Blood. 120(21). 1717–1717. 1 indexed citations
10.
Bolufer, Pascual, Dolors Colomer, María Teresa Gómez‐Casares, et al.. (2004). Quantitative Assessment of PML-RARa and BCR-ABL by Two Real-Time PCR Instruments: Multiinstitutional Laboratory Trial. Clinical Chemistry. 50(6). 1088–1092. 8 indexed citations
11.
Román‐Gómez, José, Juan A. Castillejo, Antonio Jiménez, et al.. (2003). Cadherin-13, a Mediator of Calcium-Dependent Cell-Cell Adhesion, Is Silenced by Methylation in Chronic Myeloid Leukemia and Correlates With Pretreatment Risk Profile and Cytogenetic Response to Interferon Alfa. Journal of Clinical Oncology. 21(8). 1472–1479. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chandrakala Shanmukhaiah Breakdown of academic impact, for papers by Carme Talarn Breakdown of academic impact, for papers by Bernardine Favre Breakdown of academic impact, for papers by S. A. Wang Breakdown of academic impact, for papers by Paweł Kuś Breakdown of academic impact, for papers by Alexander Sternberg Breakdown of academic impact, for papers by Zonghong Shao Breakdown of academic impact, for papers by Tiago Maié Breakdown of academic impact, for papers by H. Kreipe Breakdown of academic impact, for papers by Friederike Pastore
Rankless by CCL
2026